Hans-Peter Deigner currently is Professor of Pharmacology and Vice Dean of the new faculty of Medical and Life Sciences (Furtwangen University, Germany, http://www.hs-furtwangen.de/ ), also holds an affiliation with Fraunhofer, IZI (Leipzig, Germany). During the past years he applied metabolomics to identify and develop biomarkers at Fraunhofer Institute IZI / EXIM, Rostock, Germany and Biocrates AG, Innsbruck, Austria.
Hans-Peter has extensive experience in omics and biomarker research including several senior management positions positions in Biotech companies. He authors about 75 peer reviewed articles and 40 patents / patent applications and is a regular reviewer for numerous scientific journals and funding agencies. While holding senior management positions in biotech industry he has developed novel molecular diagnostics from the idea via the prototype to the final commercial product. From 2004-2006 he took up a chair in Biomedicinal Chemistry, University of East Anglia, Norwich, UK. Hans-Peter Deigner graduated in pharmaceutical chemistry, Heidelberg University, Germany and after a position as research associate at Harvard Medical School returned to Heidelberg to finish his habilitation and to work as group leader and senior lecturer/associate professor. His current research interests comprise the integration of omics data and its combinatorial use in biospecimen & biomarker research, systems biology, molecular diagnostics and individualized therapy.
